Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine,<i>Rotarix™</i>
Gary Dubin(Takeda (Switzerland)), S. Debrus(GlaxoSmithKline (Belgium)), Sylviane Poncelet(GlaxoSmithKline (Belgium)), Jean-Pol Cassart(GlaxoSmithKline (Belgium)), Donna Boyce(Pfizer (United States)), Leonard R. Friedland(GlaxoSmithKline (United States)), Jean‐François Toussaint(Université Paris Cité), Barbara J. Howe(GlaxoSmithKline (United States)), Remon Abu‐Elyazeed(GlaxoSmithKline (United States)), Htay Htay Han
Cited by 46
Related Papers
ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES
|Unknown|2006|940
Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments
|Journal of Virological Methods|2006|342
Bluetongue in northern Europe
|Veterinary Record|2006|157